CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 676 - 700 of 740

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0004-C02309	C02309	Serious adverse event indicator	The indicator of whether the adverse event is serious.	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20391	C20391	Sex type	The sex of the subject/participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20399	C20399	Serious averse event end treatment indicator	Indicate whether the study was discontinued due to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20406	C20406	Serious adverse events comment text	Provide any additional information that pertains to the adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20414	C20414	Investigator assessment intervention withdrawal specify text	The free-text field to specify the details of the withdrawal of study intervention that might have caused the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20400	C20400	Serious adverse event resolution indicator	Indicator to ask whether an adverse event ended after treatment with the study protocol drug or agent was stopped	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02310	C02310	Adverse event CTCAE low level term name	Text that represents the Common Terminology Criteria for Adverse Events (CTCAE) low level term name for an adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20392	C20392	Serious adverse event treatment description text	The text that describes the interventions specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20407	C20407	Adverse event reporting identifier name	A name of an authorized group or person reporting the adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20415	C20415	Serious adverse event report completed date	Date when the report on the adverse event was completed	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20401	C20401	Serious adverse event reappearance indicator	Indicate whether the adverse event reappeared after the treatment was restarted	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C00008	C00008	Age value	Value for participant's age, calculated as elapsed time since the birth of the participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02311	C02311	Adverse event MedDRA lower level term code	Code that corresponds to the Medical Dictionary for Regulatory Activities (MedDRA) Lower Level Term (LLT) for an adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20393	C20393	Serious adverse event start date and time	Date (and time, if applicable and known) on which the serious adverse event was first evident	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20408	C20408	Serious adverse event report type	Specify which type of report is being completed for the adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0001-C00012	C00012	Education level USA type	Highest grade or level of school participant/subject has completed or the highest degree received	Supplemental	Social Status	False	General (For all diseases)	General (For all diseases)
F0001-C00207	C00207	Marital or partner status	Status of participant/subject's current domestic relationship, whether marital or partnered	Supplemental	Social Status	False	General (For all diseases)	General (For all diseases)
F0017-C18740	C18740	Off study intervention prematurely other text	The free-text field related to 'Off study intervention prematurely reason' specifying other text. Primary reason participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02200	C02200	Last study intervention date and time	Date (and time, if applicable) of the last known study intervention that the participant/subject received	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02201	C02201	Off study intervention prematurely indicator	Indicator that participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02202	C02202	Off study date and time	Date (and time, if applicable and known) when participant/subject completes study or is prematurely withdrawn from study (i.e., is not being followed and will not receive intervention/treatment)	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02203	C02203	Off study reason	Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment)	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02222	C02222	Off study intervention prematurely reason	Primary reason participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0022-C02021	C02021	Study drug expected taken count	Count of expected amount of study drug taken	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02004	C02004	Study drug dispensed date and time	Date (and time, if applicable and known) on which a participant/subject was given or applied a therapeutic agent (drug, intervention therapy) used in a clinical trial protocol	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)

Displaying 676 - 700 of 740

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.